Kidney disease linked to prostate obstruction

Article

Men who experience signs and symptoms of prostate obstruction resulting from BPH are three times more likely to develop chronic kidney disease, according to a community-based study from the Mayo Clinic, Rochester, MN.

Men who experience signs and symptoms of prostate obstruction resulting from BPH are three times more likely to develop chronic kidney disease, according to a community-based study from the Mayo Clinic, Rochester, MN.

"We were surprised at how much kidney disease can be attributed to BPH," said co-author Steven Jacobsen, MD, PhD. "An obstruction on the urethra is like a dam on a river—men can still void, but the constant build-up and pressure will ultimately cause damage."

The study included 476 symptomatic and non-symptomatic Caucasian men, aged 40 to 79 years, randomly selected from Olmsted County, MN. After adjusting for age, hypertension, diabetes, leukocyte esterase positive (possible urinary tract infection), and smoking, chronic kidney disease was associated with diminished peak urinary flow rate (<15 mL/s) by an odds ratio of 2.96, moderate-severe lower urinary tract symptoms (IPSS >7) by an OR of 2.91, and chronic urinary retention (post-void residual >100 mL) by an OR of 2.28, the authors reported.

The researchers said they would like to see if similar findings are reproduced among other general populations and if further research and testing will determine if treating BPH reverses the progression of kidney disease.

"This is the first study on the topic to sample the general community," said Andrew Rule, MD, also a co-author. "Symptomatic and non-symptomatic men were compared, unlike clinical trials and studies in a urology practice, which tend to represent only symptomatic men."

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.